Skip to main content
. 2018 Sep 25;9(11):1461–1469. doi: 10.1111/1759-7714.12859

Figure 2.

Figure 2

(a) Proportion of patients who did not undergo EGFR testing. (Inline graphic) No testing although physician recommended test, (Inline graphic) No testing because physician did not recommend test, (Inline graphic) other reasons, and (Inline graphic) unknown reasons. (b) Patient reasons for declining EGFR testing although a physician recommended the test. TKI, tyrosine kinase inhibitor. (Inline graphic) High detection fee, (Inline graphic) expensive TKI, (Inline graphic) unknown, and (Inline graphic) time constraint.